Effectiveness of the Recombinant Zoster Vaccine in Adults Aged 50 and Older in the United States: A Claims-Based Cohort Study is a dataset published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 3.4, placing it in the top 6.6% of the data-sharing corpus. It has been cited 91 times, with 85 citing works in its 1-hop citation network.
Ranks in the top 7% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.678
From this paper's citation signal
Citation Network Contribution
2.7
From 62 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 85 citers.
National Eye Institute
Grant: EY06190
Office of Research on Women's Health
Grant: R01 EY028739
National Institutes of Health
Grant: 2R01EY028739-06
The Impact of the Herpes Zoster Vaccine on Herpes Zoster Ophthalmicus
National Institutes of Health
Grant: 5F32EY006190-02
NEURONAL INVOLVEMENT IN OCULAR HERPETIC DISEASE
University of California
National Institutes of Health
NIH HHS
University of California
NIH HHS
FWCI
7.14
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals